​

Merus (MRUS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

MRUS Stock Forecast

Merus (MRUS) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $80.00, with a high of $95.00 and a low of $72.00. This represents a 90.89% increase from the last price of $41.91.

$25 $39 $53 $67 $81 $95 High: $95 Avg: $80 Low: $72 Last Closed Price: $41.91

MRUS Stock Rating

Merus stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (94.12%), 1 Hold (5.88%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 1 16 Strong Sell Sell Hold Buy Strong Buy

MRUS Price Target Upside V Benchmarks

TypeNameUpside
StockMerus90.89%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts--13
Avg Price Target--$81.23
Last Closing Price$41.91$41.91$41.91
Upside/Downside--93.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25413---17
Mar, 25513---18
Feb, 25412---16
Jan, 25412---16
Dec, 24412---16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Etzer DaroutBMO Capital$95.00$48.5395.76%126.68%
Nov 21, 2024Richard LawGoldman Sachs$73.00$50.7443.87%74.18%
Oct 24, 2024David DaiUBS$72.00$52.3137.64%71.80%
Aug 05, 2024Ami FadiaNeedham$85.00$50.1469.53%102.82%
Jun 17, 2024Bradley CaninoStifel Nicolaus$99.00$56.5575.07%136.22%
Jun 04, 2024Asthika GoonewardeneTruist Financial$88.00$52.9466.23%109.97%
Jun 04, 2024Etzer DaroutBMO Capital$91.00$52.9471.89%117.13%
Jun 04, 2024John NewmanCanaccord Genuity$67.00$52.9426.56%59.87%
May 29, 2024Andrew FeinH.C. Wainwright$85.00$54.8754.91%102.82%
May 28, 2024Etzer DaroutBMO Capital$84.00$53.8655.96%100.43%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 02, 2024H.C. WainwrightBuyBuyhold
Nov 21, 2024Goldman SachsBuyinitialise
Oct 24, 2024UBSBuyinitialise
Oct 01, 2024GuggenheimBuyBuyhold
Aug 05, 2024NeedhamBuyBuyhold
Jun 26, 2024CitigroupBuyBuyhold
May 29, 2024Bank of America SecuritiesBuyBuyhold
May 28, 2024CitigroupBuyBuyhold
May 28, 2024NeedhamBuyBuyhold
May 24, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.92$-1.73$-2.92$-3.00$-3.35----
Avg Forecast$-2.12$-1.85$-2.07$-2.48$-3.70$-3.75$-3.75$-2.51$-2.09
High Forecast$-0.78$-0.68$-1.02$-2.27$-3.49$-2.98$-2.27$5.03$-0.72
Low Forecast$-4.03$-3.51$-3.24$-2.80$-4.13$-4.64$-5.34$-6.95$-3.31
Surprise %37.74%-6.49%41.06%20.97%-9.46%----

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$29.94M$49.11M$41.59M$43.95M$36.13M----
Avg Forecast$30.66M$46.25M$41.75M$46.99M$36.61M$53.12M$80.05M$252.82M$448.20M
High Forecast$51.90M$78.30M$59.81M$49.63M$52.10M$76.95M$81.59M$254.18M$649.26M
Low Forecast$15.75M$23.76M$25.38M$44.49M$29.77M$26.23M$78.51M$251.46M$221.31M
Surprise %-2.33%6.18%-0.39%-6.47%-1.30%----

Net Income Forecast

$-400M $-260M $-120M $20M $160M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-85.51M$-66.82M$-131.19M$-154.94M$-215.33M----
Avg Forecast$-109.52M$-68.51M$-75.33M$-154.94M$-196.45M$-196.54M$-196.28M$-159.21M$-108.00M
High Forecast$-40.30M$-54.80M$-60.27M$-123.95M$-180.01M$-153.77M$-117.11M$259.56M$-36.93M
Low Forecast$-208.19M$-82.21M$-90.40M$-185.93M$-212.88M$-239.30M$-275.45M$-358.75M$-170.99M
Surprise %-21.92%-2.47%74.15%-9.61%----

MRUS Forecast FAQ

Is Merus stock a buy?

Merus stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Merus is a favorable investment for most analysts.

What is Merus's price target?

Merus's price target, set by 17 Wall Street analysts, averages $80 over the next 12 months. The price target range spans from $72 at the low end to $95 at the high end, suggesting a potential 90.89% change from the previous closing price of $41.91.

How does Merus stock forecast compare to its benchmarks?

Merus's stock forecast shows a 90.89% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Merus over the past three months?

  • April 2025: 23.53% Strong Buy, 76.47% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 27.78% Strong Buy, 72.22% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Merus’s EPS forecast?

Merus's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.75, marking a 11.94% increase from the reported $-3.35 in 2024. Estimates for the following years are $-3.75 in 2026, $-2.51 in 2027, and $-2.09 in 2028.

What is Merus’s revenue forecast?

Merus's average annual revenue forecast for its fiscal year ending in December 2025 is $53.12M, reflecting a 47.01% increase from the reported $36.13M in 2024. The forecast for 2026 is $80.05M, followed by $252.82M for 2027, and $448.2M for 2028.

What is Merus’s net income forecast?

Merus's net income forecast for the fiscal year ending in December 2025 stands at $-197M, representing a -8.73% decrease from the reported $-215M in 2024. Projections indicate $-196M in 2026, $-159M in 2027, and $-108M in 2028.